{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T06:11:23Z","timestamp":1780985483371,"version":"3.54.1"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2009,11,29]],"date-time":"2009-11-29T00:00:00Z","timestamp":1259452800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Osteoporos Rep"],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.1007\/s11914-009-0021-4","type":"journal-article","created":{"date-parts":[[2009,11,28]],"date-time":"2009-11-28T05:52:38Z","timestamp":1259387558000},"page":"118-126","source":"Crossref","is-referenced-by-count":51,"title":["Bone loss or lost bone: Rationale and recommendations for the diagnosis and treatment of early postmenopausal bone loss"],"prefix":"10.1007","volume":"7","author":[{"given":"Mone","family":"Zaidi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles H.","family":"Turner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernesto","family":"Canalis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Pacifici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jameel","family":"Iqbal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X. Edward","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart","family":"Silverman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Solomon","family":"Epstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clifford J.","family":"Rosen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,11,29]]},"reference":[{"key":"21_CR1","first-page":"68","volume-title":"Bone Health and Osteoporosis: A Report of the Surgeon General","author":"L.S. Stepnick","year":"2004","unstructured":"Stepnick LS: The frequency of bone disease. In Bone Health and Osteoporosis: A Report of the Surgeon General. Edited by McGowan JA, Raisz LG, Noonan AS, Elderkin AL. Washington, DC: Office of the US Surgeon General; 2004:68\u201387."},{"key":"21_CR2","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1038\/nm1593","volume":"13","author":"M. Zaidi","year":"2007","unstructured":"Zaidi M: Skeletal remodeling in health and disease. Nat Med 2007, 13:791\u2013801.","journal-title":"Nat Med"},{"key":"21_CR3","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s11154-006-9006-0","volume":"7","author":"P.D. Miller","year":"2006","unstructured":"Miller PD: Guidelines for the diagnosis of osteoporosis: Tscores vs fractures. Rev Endocrinol Metabol Disord 2006, 7:75\u201389.","journal-title":"Rev Endocrinol Metabol Disord"},{"key":"21_CR4","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1196\/annals.1346.039","volume":"1068","author":"C.H. Turner","year":"2006","unstructured":"Turner CH: Bone strength: current concepts. Ann N Y Acad Sci 2006, 1068:429\u2013446.","journal-title":"Ann N Y Acad Sci"},{"key":"21_CR5","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1359\/JBMR.050814","volume":"20","author":"N.B. Watts","year":"2005","unstructured":"Watts NB, Geusens P, Barton IP, Felsenberg D: Relationship between changes in BMD and nonvertebral fracture incidence associated with risedronate: reduction in risk of nonvertebral fracture is not related to change in BMD. J Bone Miner Res 2005, 20:2097\u20132104.","journal-title":"J Bone Miner Res"},{"key":"21_CR6","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0002-9343(01)01124-X","volume":"112","author":"S.R. Cummings","year":"2002","unstructured":"Cummings SR, Karpf DB, Harris F, et al.: Improvement in spine bone density and reduction in risk of vertebral fractures during treatment with antiresorptive drugs. Am J Med 2002, 112:281\u2013289.","journal-title":"Am J Med"},{"key":"21_CR7","unstructured":"FRAX: WHO Fracture Risk Assessment Tool. Available at http:\/\/www.sheffield.ac.uk\/FRAX . Accessed October 1, 2009."},{"key":"21_CR8","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1210\/jc.2005-1836","volume":"91","author":"M.R. Sowers","year":"2006","unstructured":"Sowers MR, Jannausch M, McConnell D, et al.: Hormone predictors of bone mineral density changes during the menopausal transition. J Clin Endocrinol Metab 2006, 91:1261\u20131267.","journal-title":"J Clin Endocrinol Metab"},{"key":"21_CR9","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.bone.2007.03.019","volume":"41","author":"M.P. Akhter","year":"2007","unstructured":"Akhter MP, Lappe JM, Davies KM, Recker RR: Transmenopausal changes in trabecular bone structure. Bone 2007, 41:111\u2013116.","journal-title":"Bone"},{"key":"21_CR10","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1359\/jbmr.070315","volume":"22","author":"N.D. Nguyen","year":"2007","unstructured":"Nguyen ND, Ahlborg HG, Center JR, et al.: Residual lifetime risk of fracture in men and women. J Bone Miner Res 2007, 22:781\u2013788.","journal-title":"J Bone Miner Res"},{"key":"21_CR11","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1359\/jbmr.2003.18.12.2083","volume":"18","author":"S. Epstein","year":"2003","unstructured":"Epstein S, Inzerillo AM, Caminis J, Zaidi M: Disorders associated with acute rapid and severe bone loss. J Bone Miner Res 2003, 18:2083\u20132084.","journal-title":"J Bone Miner Res"},{"key":"21_CR12","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1007\/s00198-007-0394-0","volume":"18","author":"E. Canalis","year":"2007","unstructured":"Canalis E, Mazziotti G, Giustina A, Bilezikian J: Glucocorticoid-induced osteoporosis: pathophysiology and therapy. Osteoporosis Int 2007, 18:1319\u20131328.","journal-title":"Osteoporosis Int"},{"key":"21_CR13","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/8756-3282(95)00370-3","volume":"17","author":"M.B. Schaffler","year":"1995","unstructured":"Schaffler MB, Choi K, Milgrom C: Aging and matrix microdamage accumulation in human compact bone. Bone 1995, 17:521\u2013525.","journal-title":"Bone"},{"key":"21_CR14","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.bone.2003.10.001","volume":"34","author":"S.C. Schuit","year":"2004","unstructured":"Schuit SC, van der Klift M, Weel AE, et al.: Fracture incidence and association with bone mineral density in elderly men and women: the Rotterdam Study. Bone 2004, 34:195\u2013202.","journal-title":"Bone"},{"key":"21_CR15","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1359\/jbmr.2002.17.1.1","volume":"17","author":"S. Sarkar","year":"2002","unstructured":"Sarkar S, Mitlak BH, Wong M, et al.: Relationships between bone mineral density and incident vertebral fracture risk with raloxifene therapy. J Bone Miner Res 2002, 17:11\u201314.","journal-title":"J Bone Miner Res"},{"key":"21_CR16","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1359\/jbmr.2000.15.1.20","volume":"15","author":"D.W. Dempster","year":"2000","unstructured":"Dempster DW: The contribution of trabecular architecture to cancellous bone quality. J Bone Miner Res 2000, 15:20\u201323.","journal-title":"J Bone Miner Res"},{"key":"21_CR17","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1359\/jbmr.060313","volume":"21","author":"C. Li","year":"2006","unstructured":"Li C: Mice lacking cathepsin K maintain bone remodeling but develop bone fragility despite high bone mass. J Bone Miner Res 2006, 21:865\u2013875.","journal-title":"J Bone Miner Res"},{"key":"21_CR18","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1172\/JCI117901","volume":"95","author":"M.H. Lafage","year":"1995","unstructured":"Lafage MH, Balena R, Battle MA, et al.: Comparison of alendronate and sodium fluoride effects on cancellous and cortical bone in mini-pigs. A one-year study. J Clin Invest 1995, 95:2127\u20132133.","journal-title":"J Clin Invest"},{"key":"21_CR19","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1196\/annals.1402.042","volume":"1117","author":"S.L. Silverman","year":"2007","unstructured":"Silverman SL: Selecting patients for osteoporosis therapy. Ann N Y Acad Sci 2007, 1117:264\u2013272.","journal-title":"Ann N Y Acad Sci"},{"key":"21_CR20","doi-asserted-by":"crossref","unstructured":"Sandhu SK, Nguyen ND, Center JR, et al.: Prognosis of fracture: evaluation of predictive accuracy of the FRAX algorithm and Garvan nomogram. Osteoporosis Int 2009 Jul 25 (Epub ahead of print).","DOI":"10.1007\/s00198-009-1026-7"},{"key":"21_CR21","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s00198-002-1307-x","volume":"14","author":"M.R. Sowers","year":"2003","unstructured":"Sowers MR, Greendale GA, Bondarenko I, et al.: Endogenous hormones and bone turnover markers in pre- and perimenopausal women: SWAN. Osteoporosis Int 2003, 14:191\u2013197.","journal-title":"Osteoporosis Int"},{"key":"21_CR22","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0378-5122(01)00248-1","volume":"41","author":"V. Seifert-Klauss","year":"2002","unstructured":"Seifert-Klauss V, Mueller JE, Luppa P, et al.: Bone metabolism during the perimenopausal transition: a prospective study. Maturitas 2002, 41:23\u201333.","journal-title":"Maturitas"},{"key":"21_CR23","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1359\/JBMR.040710","volume":"19","author":"R. Recker","year":"2004","unstructured":"Recker R, Lappe J, Davies KM, Heaney R: Bone remodeling increases substantially in the years after menopause and remains increased in older osteoporosis patients. J Bone Miner Res 2004, 19:1628\u20131633.","journal-title":"J Bone Miner Res"},{"key":"21_CR24","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1359\/jbmr.060716","volume":"21","author":"X.S. Liu","year":"2006","unstructured":"Liu XS, Sajda P, Saha PK, et al.: Quantification of the roles of trabecular microarchitecture and trabecular type in determining the elastic modulus of human trabecular bone. J Bone Miner Res 2006, 21:1608\u20131617.","journal-title":"J Bone Miner Res"},{"key":"21_CR25","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1016\/j.amjmed.2005.12.020","volume":"119S","author":"S.L. Bonnick","year":"2006","unstructured":"Bonnick SL, Shulman I: Monitoring osteoporosis therapy: bone mineral density, bone turnover markers or both? Am J Med 2006, 119S:S25\u2013S31.","journal-title":"Am J Med"},{"key":"21_CR26","first-page":"3366","volume":"81","author":"P.R. Ebeling","year":"1996","unstructured":"Ebeling PR, Atley LM, Guthrie JR, et al.: Bone turnover markers and bone density across the menopausal transition. J Clin Endocrinol Metab 1996, 81:3366\u20133371.","journal-title":"J Clin Endocrinol Metab"},{"key":"21_CR27","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s001980070091","volume":"11","author":"R.D. Chapurlat","year":"2000","unstructured":"Chapurlat RD, Garnero P, Sornay-Rendu E, et al.: Longitudinal study of bone loss in pre and perimenopausal women: evidence for bone loss in perimenopausal women. Osteoporosis Int 2000, 11:493\u2013498.","journal-title":"Osteoporosis Int"},{"key":"21_CR28","first-page":"1904","volume":"82","author":"C.J. Rosen","year":"1997","unstructured":"Rosen CJ, Chestnut CH III, Mallinak NJ: The predictive value of biochemical markers of bone turnover for bone mineral density in early postmenopausal women treated with hormone replacement or calcium supplementation. J Clin Endocrinol Metab 1997, 82:1904\u20131910.","journal-title":"J Clin Endocrinol Metab"},{"key":"21_CR29","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1007\/s00198-006-0160-8","volume":"17","author":"E. Seeman","year":"2006","unstructured":"Seeman E, Bianchi G, Khosla S, et al.: Bone fragility in men: where are we? Osteoporosis Int 2006, 17:1577\u20131583.","journal-title":"Osteoporosis Int"},{"key":"21_CR30","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1359\/JBMR.050916","volume":"21","author":"S. Khosla","year":"2006","unstructured":"Khosla S, Riggs BL, Atkinson EJ, et al.: Effects of sex and age on bone microstructure at the ultradistal radius: a population-based non-invasive in vivo assessment. J Bone Miner Res 2006, 21:124\u2013131.","journal-title":"J Bone Miner Res"},{"key":"21_CR31","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1359\/jbmr.061011","volume":"22","author":"T.M. Keaveny","year":"2007","unstructured":"Keaveny TM, Donley DW, Hoffmann PF, et al.: Effects of teriparatide and alendronate on vertebral strength as assessed by finite element modeling of QCT scans in women with osteoporosis. J Bone Miner Res 2007, 22:149\u2013157.","journal-title":"J Bone Miner Res"},{"key":"21_CR32","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1007\/s00198-006-0187-x","volume":"17","author":"M. Kleerekoper","year":"2006","unstructured":"Kleerekoper M: Osteoporosis prevention and therapy: preserving and building strength through bone quality. Osteoporosis Int 2006, 17:1707\u20131715.","journal-title":"Osteoporosis Int"},{"key":"21_CR33","doi-asserted-by":"crossref","first-page":"4879","DOI":"10.1210\/jc.2003-031672","volume":"89","author":"M.R. McClung","year":"2004","unstructured":"McClung MR, Wasnich RD, Hosking DJ, et al.: Prevention of postmenopausal bone loss: six year results from the Early Postmenopausal Intervention Cohort Study. J Clin Endocrinol Metab 2004, 89:4879\u20134885.","journal-title":"J Clin Endocrinol Metab"},{"key":"21_CR34","first-page":"1492","volume":"85","author":"P. Ravn","year":"2000","unstructured":"Ravn P, Weiss SR, Rodriguez-Portales JA, et al.: Alendronate in early post-menopausal women: effects on bone mass during long-term treatment and after withdrawal. Alendronate Osteoporosis Prevention Study Group. J Clin Endocrinol Metab 2000, 85:1492\u20131497.","journal-title":"J Clin Endocrinol Metab"},{"key":"21_CR35","first-page":"396","volume":"83","author":"L. Mortensen","year":"1998","unstructured":"Mortensen L, Charles P, Bekker PJ, et al.: Risedronate increases bone mass in an early post-menopausal population: two years of treatment plus one year of follow-up. J Clin Endocrinol Metab 1998, 83:396\u2013402.","journal-title":"J Clin Endocrinol Metab"},{"key":"21_CR36","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1080\/13697130500118126","volume":"8","author":"M.J. Hooper","year":"2005","unstructured":"Hooper MJ, Ebeling PR, Roberts AP, et al.: Risedronate prevents bone loss in early post-menopausal women: a prospective, randomized, placebo-controlled trial. Climacteric 2005, 8:251\u2013262.","journal-title":"Climacteric"},{"key":"21_CR37","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.1001\/jama.296.24.2927","volume":"296","author":"D.M. Black","year":"2006","unstructured":"Black DM, Schwartz AV, Ensrud KE, et al.: Effects of continuing or stopping alendronate after 5 years of treatment the Fracture Intervention Trial Long-arm Extension (FLEX): a randomized trial. JAMA 2006, 296:2927\u20132938.","journal-title":"JAMA"},{"key":"21_CR38","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1359\/jbmr.0301202","volume":"19","author":"M.R. McClung","year":"2004","unstructured":"McClung MR, Wasnich RD, Recker R, et al.: Oral daily ibandronate prevents bone loss in early postmenopausal women without osteoporosis. J Bone Miner Res 2004, 19:11\u201318.","journal-title":"J Bone Miner Res"},{"key":"21_CR39","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1210\/jcem-69-3-533","volume":"69","author":"K.K. Steinberg","year":"1989","unstructured":"Steinberg KK, Freni-Titulaer LW, DePuey EG, et al.: Sex steroids and bone density in premenopausal and perimenopausal women. J Clin Endocrinol Metab 1989, 69:533\u2013539.","journal-title":"J Clin Endocrinol Metab"},{"key":"21_CR40","first-page":"120","volume":"40","author":"G. Perrone","year":"1995","unstructured":"Perrone G, Galoppi P, Capri O, et al.: Lumbar and femoral bone density in perimenopausal women with irregular cycles. Int J Fertil Menopausal Stud 1995, 40:120\u2013125.","journal-title":"Int J Fertil Menopausal Stud"},{"key":"21_CR41","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s001980050243","volume":"10","author":"M. Ito","year":"1999","unstructured":"Ito M, Nakamura T, Tsurusaki K, et al.: Effects of menopause on age-dependent bone loss in the axial and appendicular skeletons in healthy Japanese women. Osteoporosis Int 1999, 10:377\u2013383.","journal-title":"Osteoporosis Int"},{"key":"21_CR42","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1359\/jbmr.2000.15.10.1965","volume":"15","author":"R. Recker","year":"2001","unstructured":"Recker R, Lappe J, Davies K, Heaney R: Characterization of perimenopausal bone loss: a prospective study. J Bone Miner Res 2001, 15:1965\u20131973.","journal-title":"J Bone Miner Res"},{"key":"21_CR43","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1007\/s00198-002-1307-x","volume":"14","author":"M.R. Sowers","year":"2003","unstructured":"Sowers MR, Finkelstein JS, Ettinger, B, et al.: The association of endogenous hormone concentrations and bone mineral density measures in pre- and perimenopausal women of four ethnic groups: SWAN. Osteoporosis Int 2003, 14:44\u201352.","journal-title":"Osteoporosis Int"},{"key":"21_CR44","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.maturitas.2006.04.024","volume":"55","author":"V. Seifert-Klauss","year":"2006","unstructured":"Seifert-Klauss V, Link T, Heumann C, et al.: Influence of pattern of menopausal transition on amount of trabecular bone loss. Results from a 6-year prospective longitudinal study. Maturitas 2006, 55:317\u2013324.","journal-title":"Maturitas"},{"key":"21_CR45","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1210\/jc.2003-031183","volume":"89","author":"J.F. Randolph Jr","year":"2004","unstructured":"Randolph JF Jr, Sowers M, Bondarenko IV, et al.: Change in estradiol and follicle-stimulating hormone across the early menopausal transition: effects of ethnicity and age. J Clin Endocrinol Metab 2004, 89:1555\u20131561.","journal-title":"J Clin Endocrinol Metab"},{"key":"21_CR46","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/S8756-3282(01)00673-1","volume":"30","author":"X.E. Guo","year":"2002","unstructured":"Guo XE, Kim CH: Mechanical consequence of trabecular bone loss and its treatment: a three-dimensional model simulation. Bone 2002, 30:404\u2013411.","journal-title":"Bone"}],"container-title":["Current Osteoporosis Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11914-009-0021-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11914-009-0021-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11914-009-0021-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T00:33:45Z","timestamp":1559435625000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11914-009-0021-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,11,29]]},"references-count":46,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["21"],"URL":"https:\/\/doi.org\/10.1007\/s11914-009-0021-4","relation":{},"ISSN":["1544-1873","1544-2241"],"issn-type":[{"value":"1544-1873","type":"print"},{"value":"1544-2241","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,11,29]]}}}